JP2024517644A5 - - Google Patents

Info

Publication number
JP2024517644A5
JP2024517644A5 JP2023564141A JP2023564141A JP2024517644A5 JP 2024517644 A5 JP2024517644 A5 JP 2024517644A5 JP 2023564141 A JP2023564141 A JP 2023564141A JP 2023564141 A JP2023564141 A JP 2023564141A JP 2024517644 A5 JP2024517644 A5 JP 2024517644A5
Authority
JP
Japan
Application number
JP2023564141A
Other languages
Japanese (ja)
Other versions
JPWO2022226008A5 (https=
JP2024517644A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/025455 external-priority patent/WO2022226008A2/en
Publication of JP2024517644A publication Critical patent/JP2024517644A/ja
Publication of JP2024517644A5 publication Critical patent/JP2024517644A5/ja
Publication of JPWO2022226008A5 publication Critical patent/JPWO2022226008A5/ja
Pending legal-status Critical Current

Links

JP2023564141A 2021-04-20 2022-04-20 カチオン性脂質及びその組成物 Pending JP2024517644A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163176943P 2021-04-20 2021-04-20
US63/176,943 2021-04-20
US202163217869P 2021-07-02 2021-07-02
US63/217,869 2021-07-02
PCT/US2022/025455 WO2022226008A2 (en) 2021-04-20 2022-04-20 Cationic lipids and compositions thereof

Publications (3)

Publication Number Publication Date
JP2024517644A JP2024517644A (ja) 2024-04-23
JP2024517644A5 true JP2024517644A5 (https=) 2025-04-28
JPWO2022226008A5 JPWO2022226008A5 (https=) 2025-04-28

Family

ID=83723777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023564141A Pending JP2024517644A (ja) 2021-04-20 2022-04-20 カチオン性脂質及びその組成物

Country Status (11)

Country Link
US (3) US20240226325A1 (https=)
EP (1) EP4326235A4 (https=)
JP (1) JP2024517644A (https=)
KR (1) KR20230172570A (https=)
AU (1) AU2022262592A1 (https=)
BR (1) BR112023021504A2 (https=)
CA (1) CA3215324A1 (https=)
CO (1) CO2023015501A2 (https=)
IL (1) IL307758A (https=)
MX (1) MX2023012369A (https=)
WO (1) WO2022226008A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230172570A (ko) * 2021-04-20 2023-12-22 제너레이션 바이오 컴퍼니 양이온성 지질 및 이의 조성물
WO2024119103A1 (en) * 2022-12-01 2024-06-06 Generation Bio Co. Lipid nanoparticles comprising nucleic acids and lipid-anchored polymers
JP2025540076A (ja) * 2022-12-01 2025-12-11 ジェネレーション バイオ カンパニー 核酸、イオン化可能な脂質、ステロール、脂質アンカーポリマー、及びヘルパー脂質を含む脂質ナノ粒子、それらの使用
KR20250131271A (ko) * 2022-12-01 2025-09-02 제너레이션 바이오 컴퍼니 신규한 폴리글리세롤-접합된 지질 및 이를 포함하는 지질 나노입자 조성물
EP4683905A1 (en) * 2023-03-22 2026-01-28 Nanovation Therapeutics Inc. Ionizable anionic lipids
CN121532216A (zh) * 2023-04-18 2026-02-13 赛仁生物技术公司 腺相关病毒载体组合物和使用方法
US12311033B2 (en) 2023-05-31 2025-05-27 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
KR102875269B1 (ko) * 2024-06-03 2025-10-24 주식회사 에스엠엘바이오팜 비대칭 구조를 가지는 지질 화합물 및 이를 포함하는 지질 나노 입자 조성물
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG186085A1 (en) * 2010-06-03 2013-01-30 Alnylam Pharmaceuticals Inc Biodegradable lipids for the delivery of active agents
HK1206644A1 (en) * 2012-03-29 2016-01-15 Shire Human Genetic Therapies, Inc. Lipid-derived neutral nanoparticles
AU2013249548A1 (en) * 2012-04-19 2014-11-06 Sirna Therapeutics, Inc. Novel diester and triester based low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
EP4019506A1 (en) * 2013-12-19 2022-06-29 Novartis AG Lipids and lipid compositions for the delivery of active agents
WO2019188867A1 (ja) * 2018-03-27 2019-10-03 日油株式会社 細胞内動態を改善した新規カチオン性脂質
PL3805198T3 (pl) * 2018-06-08 2024-02-12 Fujifilm Corporation Związek, jego sól i cząstki lipidowe
US20210369862A1 (en) * 2018-09-18 2021-12-02 Universiteit Gent Therapeutic nanoparticles and methods of use thereof
MX2023000806A (es) * 2020-07-17 2023-04-11 Generation Bio Co Métodos para encapsular polinucleótidos en tamaños reducidos de nanopartículas lipídicas y formulación novedosa de estos.
KR20230172570A (ko) * 2021-04-20 2023-12-22 제너레이션 바이오 컴퍼니 양이온성 지질 및 이의 조성물

Similar Documents

Publication Publication Date Title
JP2024517644A5 (https=)
CL2025002518A1 (es) Composiciones de lactoferrina purificada y métodos de uso.
BR102023014872A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BY13141U (https=)
BY13135U (https=)
BY13162U (https=)
BY13161U (https=)
BY13160U (https=)
BY13159U (https=)
BY13158U (https=)
BY13157U (https=)
BY13156U (https=)
BY13155U (https=)
BY13153U (https=)
BY13166U (https=)
BY13149U (https=)
BY13145U (https=)
BY13144U (https=)
BY13143U (https=)
BY13142U (https=)
BY13164U (https=)